Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Increased Density of Endogenous Adenosine A2A Receptors in Atrial Fibrillation, From Cellular and Porcine Models to Human Patients

  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Ginel, Antonino|||0000-0002-8820-7545
  • Santos, Joana Larupa Dos|||0000-0002-0690-7741
  • Bentzen, Bo Hjorth
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Ciruela, Francisco|||0000-0003-0832-3739
Adenosine, an endogenous nucleoside, plays a critical role in maintaining homeostasis during stressful situations, such as energy deprivation or cellular damage. Therefore, extracellular adenosine is generated locally in tissues under conditions such as hypoxia, ischemia, or inflammation. In fact, plasma levels of adenosine in patients with atrial fibrillation (AF) are elevated, which also correlates with an increased density of adenosine A receptors (ARs) both in the right atrium and in peripheral blood mononuclear cells (PBMCs). The complexity of adenosine-mediated effects in health and disease requires simple and reproducible experimental models of AF. Here, we generate two AF models, namely the cardiomyocyte cell line HL-1 submitted to Anemonia toxin II (ATX-II) and a large animal model of AF, the right atrium tachypaced pig (A-TP). We evaluated the density of endogenous AR in those AF models. Treatment of HL-1 cells with ATX-II reduced cell viability, while the density of AR increased significantly, as previously observed in cardiomyocytes with AF. Next, we generated the animal model of AF based on tachypacing pigs. In particular, the density of the key calcium regulatory protein calsequestrin-2 was reduced in A-TP animals, which is consistent with the atrial remodelling shown in humans suffering from AF. Likewise, the density of AR in the atrium of the AF pig model increased significantly, as also shown in the biopsies of the right atrium of subjects with AF. Overall, our findings revealed that these two experimental models of AF mimicked the alterations in AR density observed in patients with AF, making them attractive models for studying the adenosinergic system in AF.
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease

  • Romero-Fernandez, Wilber
  • Taura, Jaume J.
  • Crans, René A. J.
  • Lopez-Cano, Marc
  • Fores-Pons, Ramon
  • Narváez, Manuel
  • Carlsson, Jens
  • Ciruela, Francisco
  • Fuxe, Kjell
  • Borroto-Escuela, Dasiel O.
The adenosine A2A receptor (A2AR), dopamine D2 receptor (D2R) and metabotropic glutamate receptor type 5 (mGluR5) form A2AR-D2R-mGluR5 heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the A2AR protomer plays a major role in the inhibitory modulation of the density and the allosteric receptor-receptor interaction within the D2R-mGluR5 heteromeric component of the A2AR-D2R-mGluR5 complex in vitro and in vivo. The A2AR and mGluR5 protomers interact and modulate D2R protomer recognition and signalling upon forming a trimeric complex from these receptors. Expression of A2AR in HEK293T cells co-expressing D2R and mGluR5 resulted in a significant and marked increase in the formation of the D2R-mGluR5 heteromeric component in both bioluminescence resonance energy transfer and proximity ligation assays. A highly significant increase of the the high-affinity component of D2R (D2RKi High) values was found upon cotreatment with the mGluR5 and A2AR agonists in the cells expressing A2AR, D2R and mGluR5 with a significant effect observed also with the mGluR5 agonist alone compared to cells expressing only D2R and mGluR5. In cells co-expressing A2AR, D2R and mGluR5, stimulation of the cells with an mGluR5 agonist like or D2R antagonist fully counteracted the D2R agonist-induced inhibition of the cAMP levels which was not true in cells only expressing mGluR5 and D2R. In agreement, the mGluR5-negative allosteric modulator raseglurant significantly reduced the haloperidol-induced catalepsy in mice, and in A2AR knockout mice, the haloperidol action had almost disappeared, supporting a functional role for mGluR5 and A2AR in enhancing D2R blockade resulting in catalepsy. The results represent a relevant example of integrative activity within higher-order heteroreceptor complexes., Karolinska Institutet (Open access funding), Swedish Research Council (Vetenskapsrådet), ParkinsonFonden, Hjärnfonden, Karolinska Institutet Forskningsstiftelser, Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI) – EMERGIA (Junta de Andalucía), Olle Engkvists Stiftelse, MCIN/AEI (Ministerio de Ciencia e Innovación / Agencia Estatal de Investigación, España), FEDER (Fondo Europeo de Desarrollo Regional), CERCA Programme (Generalitat de Catalunya) / IDIBELL (institutional support)
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Environmental levels of carbaryl impair zebrafish larvae behaviour: The potential role of ADRA2B and HTR2B

  • Faria, Melissa
  • Bellot, Marina
  • Bedrossiantz, Juliette
  • Rosas Ramírez, Jonathan Ricardo
  • Prats, Eva
  • Garcia-Reyero, Natàlia
  • Gómez-Canela, Cristian
  • Mestres, Jordi
  • Rovira, Xavier
  • Barata, Carlos
  • Gómez-Oliván, Leobardo Manuel
  • Llebaria, Amadeu
  • Raldúa, Demetrio
The insecticide carbaryl is commonly found in indirectly exposed freshwater ecosystems at low concentrations considered safe for fish communities. In this study, we showed that after only 24 h of exposure to environmental concentrations of carbaryl (0.066–660 ng/L), zebrafish larvae exhibit impairments in essential behaviours. Interestingly, the observed behavioural effects induced by carbaryl were acetylcholinesterase-independent. To elucidate the molecular initiating event that resulted in the observed behavioural effects, in silico predictions were followed by in vitro validation. We identified two target proteins that potentially interacted with carbaryl, the α2B adrenoceptor (ADRA2B) and the serotonin 2B receptor (HTR2B). Using a pharmacological approach, we then tested the hypothesis that carbaryl had antagonistic interactions with both receptors. Similar to yohimbine and SB204741, which are prototypic antagonists of ADRA2B and HTR2B, respectively, carbaryl increased the heart rate of zebrafish larvae. When we compared the behavioural effects of a 24-h exposure to these pharmacological antagonists with those of carbaryl, a high degree of similarity was found. These results strongly suggest that antagonism of both ADRA2B and HTR2B is the molecular initiating event that leads to adverse outcomes in zebrafish larvae that have undergone 24 h of exposure to environmentally relevant levels of carbaryl., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Environmental levels of carbaryl impair zebrafish larvae behaviour: The potential role of ADRA2B and HTR2B

  • Faria, Melissa
  • Bellot, Marina
  • Bedrossiantz, Juliette
  • Rosas Ramírez, Jonathan Ricardo
  • Prats, Eva
  • Garcia-Reyero, Natàlia
  • Gómez-Canela, Cristian
  • Mestres, Jordi
  • Rovira, Xavier
  • Barata, Carlos
  • Gómez-Oliván, Leobardo Manuel
  • Llebaria, Amadeu
  • Raldúa, Demetrio
The insecticide carbaryl is commonly found in indirectly exposed freshwater ecosystems at low concentrations considered safe for fish communities. In this study, we showed that after only 24 h of exposure to environmental concentrations of carbaryl (0.066–660 ng/L), zebrafish larvae exhibit impairments in essential behaviours. Interestingly, the observed behavioural effects induced by carbaryl were acetylcholinesterase-independent. To elucidate the molecular initiating event that resulted in the observed behavioural effects, in silico predictions were followed by in vitro validation. We identified two target proteins that potentially interacted with carbaryl, the α2B adrenoceptor (ADRA2B) and the serotonin 2B receptor (HTR2B). Using a pharmacological approach, we then tested the hypothesis that carbaryl had antagonistic interactions with both receptors. Similar to yohimbine and SB204741, which are prototypic antagonists of ADRA2B and HTR2B, respectively, carbaryl increased the heart rate of zebrafish larvae. When we compared the behavioural effects of a 24-h exposure to these pharmacological antagonists with those of carbaryl, a high degree of similarity was found. These results strongly suggest that antagonism of both ADRA2B and HTR2B is the molecular initiating event that leads to adverse outcomes in zebrafish larvae that have undergone 24 h of exposure to environmentally relevant levels of carbaryl., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Control of glutamate release by complexes of adenosine and cannabinoid receptors

  • Köfalvi, Attila
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Cai, Ning-Sheng
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ferreira, Samira G.
  • Guixà González, Ramon|||0000-0003-0397-9800
  • Sánchez Soto, Marta
  • Yano, Hideaki
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Cunha, Rodrigo A.
  • Sebastião, Ana Maria
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Casadó, Vicent|||0000-0002-1764-3825
  • Ferré, Sergi|||0000-0002-1747-1779
It has been hypothesized that heteromers of adenosine A receptors (A2AR) and cannabinoid CB receptors (CB1R) localized in glutamatergic nerve terminals mediate the integration of adenosine and endocannabinoid signaling involved in the modulation of striatal excitatory neurotransmission. Previous studies have demonstrated the existence of A2AR-CB1R heteromers in artificial cell systems. A dependence of A2AR signaling for the Gi protein-mediated CB1R signaling was described as one of its main biochemical characteristics. However, recent studies have questioned the localization of functionally significant A2AR-CB1R heteromers in striatal glutamatergic terminals. Using a peptide-interfering approach combined with biophysical and biochemical techniques in mammalian transfected cells and computational modeling, we could establish a tetrameric quaternary structure of the A2AR-CB1R heterotetramer. This quaternary structure was different to the also tetrameric structure of heteromers of A2AR with adenosine A receptors or dopamine D receptors, with different heteromeric or homomeric interfaces. The specific quaternary structure of the A2A-CB1R, which depended on intermolecular interactions involving the long C-terminus of the A2AR, determined a significant A2AR and Gs protein-mediated constitutive activation of adenylyl cyclase. Using heteromer-interfering peptides in experiments with striatal glutamatergic terminals, we could then demonstrate the presence of functionally significant A2AR-CB1R heteromers with the same biochemical characteristics of those studied in mammalian transfected cells. First, either an A2AR agonist or an A2AR antagonist allosterically counteracted Gi-mediated CB1R agonist-induced inhibition of depolarization-induced glutamate release. Second, co-application of both an A2AR agonist and an antagonist cancelled each other effects. Finally, a CB1R agonist inhibited glutamate release dependent on a constitutive activation of A2AR by a canonical Gs-Gi antagonistic interaction at the adenylyl cyclase level. We demonstrate that the well-established cannabinoid-induced inhibition of striatal glutamate release can mostly be explained by a CB1R-mediated counteraction of the A2AR-mediated constitutive activation of adenylyl cyclase in the A2AR-CB1R heteromer.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects

  • López Cano, Marc|||0000-0001-8885-3726
  • Font Inglès, Joan|||0000-0001-8416-1909
  • Aso, Ester|||0000-0003-1836-1747
  • Sahlholm, Kristoffer|||0000-0001-6536-1972
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Giraldo, Jesús|||0000-0001-7082-4695
  • De Koninck, Yves|||0000-0002-5779-9330
  • Hernando, Jordi|||0000-0002-1126-4138
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ciruela, Francisco|||0000-0003-0832-3739
Background and Purpose: Opioid-based drugs are the gold standard medicines for pain relief. However, tolerance and several side effects (i.e. constipation and dependence) may occur upon chronic opioid administration. Photopharmacology is a promising approach to improve the benefit/risk profiles of these drugs. Thus, opioids can be locally activated with high spatiotemporal resolution, potentially minimizing systemic-mediated adverse effects. Here, we aimed at developing a morphine photo-derivative (photocaged morphine), which can be activated upon light irradiation both in vitro and in vivo. Experimental Approach: Light-dependent activity of pc-morphine was assessed in cell-based assays (intracellular calcium accumulation and electrophysiology) and in mice (formalin animal model of pain). In addition, tolerance, constipation and dependence were investigated in vivo using experimental paradigms. Key results: In mice, pc-morphine was able to elicit antinociceptive effects, both using external light-irradiation (hind paw) and spinal cord implanted fibre-optics. In addition, remote morphine photoactivation was devoid of common systemic opioid-related undesired effects, namely, constipation, tolerance to the analgesic effects, rewarding effects and naloxone-induced withdrawal. Conclusion and Implications: Light-dependent opioid-based drugs may allow effective analgesia without the occurrence of tolerance or the associated and severe opioid-related undesired effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Optical control of adenosine A3 receptor function in psoriasis

  • López Cano, Marc|||0000-0001-8885-3726
  • Filgaira, Ingrid|||0000-0002-9886-3925
  • Nolen, Ernest G.
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Hernando, Jordi|||0000-0002-1126-4138
  • Tosh, Dilip K.
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Ciruela, Francisco|||0000-0003-0832-3739
Psoriasis is a chronic and relapsing inflammatory skin disease lacking a cure that affects approximately 2% of the population. Defective keratinocyte proliferation and differentiation, and aberrant immune responses are major factors in its pathogenesis. Available treatments for moderate to severe psoriasis are directed to immune system causing systemic immunosuppression over time, and thus concomitant serious side effects (i.e. infections and cancer) may appear. In recent years, the G protein-coupled A receptor (AR) for adenosine has been suggested as a novel and very promising therapeutic target for psoriasis. Accordingly, selective, and high affinity AR agonists are known to induce robust anti-inflammatory effects in animal models of autoimmune inflammatory diseases. Here, we demonstrated the efficacy of a selective AR agonist, namely MRS5698, in preventing the psoriatic-like phenotype in the IL-23 mouse model of psoriasis. Subsequently, we photocaged this molecule with a coumarin moiety to yield the first photosensitive AR agonist, MRS7344, which in photopharmacological experiments prevented the psoriatic-like phenotype in the IL-23 animal model. Thus, we have demonstrated the feasibility of using a non-invasive, site-specific, light-directed approach to psoriasis treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Remote control of movement disorders using a photoactive adenosine A 2A receptor antagonist

  • Taura, Jaume
  • Nolen, Ernest G.
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Hernando, Jordi|||0000-0002-1126-4138
  • Squarcialupi, Lucia
  • López Cano, Marc|||0000-0001-8885-3726
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ciruela, Francisco|||0000-0003-0832-3739
G protein-coupled adenosine receptors are promising therapeutic targets for a wide range of neuropathological conditions, including Parkinson's disease (PD). However, the ubiquity of adenosine receptors and the ultimate lack of selectivity of certain adenosine-based drugs have frequently diminished their therapeutic use. Photopharmacology is a novel approach that allows the spatiotemporal control of receptor function, thus circumventing some of these limitations. Here, we aimed to develop a light-sensitive caged adenosine A receptor (A R) antagonist to photocontrol movement disorders. We synthesized MRS7145 by blocking with coumarin the 5-amino position of the selective A R antagonist SCH442416, which could be photoreleased upon violet light illumination (405 nm). First, the light-dependent pharmacological profile of MRS7145 was determined in A R-expressing cells. Upon photoactivation, MRS7145 precluded A R ligand binding and agonist-induced cAMP accumulation. Next, the ability of MRS7145 to block A R in a light-dependent manner was assessed in vivo. To this end, A R antagonist-mediated locomotor activity potentiation was evaluated in brain (striatum) fiber-optic implanted mice. Upon irradiation (405 nm) of the dorsal striatum, MRS7145 induced significant hyperlocomotion and counteracted haloperidol-induced catalepsy and pilocarpine-induced tremor. Finally, its efficacy in reversing motor impairment was evaluated in a PD animal model, namely the hemiparkinsonian 6-hydroxydopamine (6-OHDA)-lesioned mouse. Photo-activated MRS7145 was able to potentiate the number of contralateral rotations induced by L-3,4-dihydroxyphenylalanine (L-DOPA). Overall, MRS7145 is a new light-operated A R antagonist with potential utility to manage movement disorders, including PD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fast Photoswitchable Molecular Prosthetics Control Neuronal Activity in the Cochlea

  • Garrido Charles, Aida|||0000-0002-9577-6682
  • Huet, Antoine|||0000-0001-6151-7183
  • Matera, Carlo|||0000-0001-6939-3859
  • Thirumalai, Anupriya|||0000-0002-3624-0343
  • Hernando, Jordi|||0000-0002-1126-4138
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Moser, Tobias|||0000-0001-7145-0533
  • Gorostiza, Pau|||0000-0002-7268-5577
Artificial control of neuronal activity enables the study of neural circuits and restoration of neural functions. Direct, rapid, and sustained photocontrol of intact neurons could overcome the limitations of established electrical stimulation such as poor selectivity. We have developed fast photoswitchable ligands of glutamate receptors (GluRs) to enable neuronal control in the auditory system. The new photoswitchable ligands induced photocurrents in untransfected neurons upon covalently tethering to endogenous GluRs and activating them reversibly with visible light pulses of a few milliseconds. As a proof of concept of these molecular prostheses, we applied them to the ultrafast synapses of auditory neurons of the cochlea that encode sound and provide auditory input to the brain. This drug-based method afforded the optical stimulation of auditory neurons of adult gerbils at hundreds of hertz without genetic manipulation that would be required for their optogenetic control. This indicates that the new photoswitchable ligands are also applicable to the spatiotemporal control of fast spiking interneurons in the brain.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adenosine a2a receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients

  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Duroux, Romain|||0000-0001-7099-1469
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Montiel, José|||0000-0002-3791-5218
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Ciruela, Francisco|||0000-0003-0832-3739
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia seen in clinical practice. While some clinical parameters may predict the transition from paroxysmal to persistent AF, the molecular mechanisms behind the AF perpetuation are poorly understood. Thus, oxidative stress, calcium overload and inflammation, among others, are believed to be involved in AF-induced atrial remodelling. Interestingly, adenosine and its receptors have also been related to AF development and perpetuation. Here, we investigated the expression of adenosine A2A receptor (A2AR) both in right atrium biopsies and peripheral blood mononuclear cells (PBMCs) from non-dilated sinus rhythm (ndSR), dilated sinus rhythm (dSR) and AF patients. In addition, plasma adenosine content and adenosine deaminase (ADA) activity in these subjects were also determined. Our results revealed increased A2AR expression in the right atrium from AF patients, as previously described. Interestingly, increased levels of adenosine content and reduced ADA activity in plasma from AF patients were detected. An increase was observed when A2AR expression was assessed in PBMCs from AF subjects. Importantly, a positive correlation (P=0.001) between A2AR expression in the right atrium and PBMCs was observed. Overall, these results highlight the importance of the A2AR in AF and suggest that the evaluation of this receptor in PBMCs may be potentially be useful in monitoring disease severity and the efficacy of pharmacological treatments in AF patients.